Cabaletta Bio, Inc

(NASDAQ:CABA)

Latest On Cabaletta Bio, Inc (CABA):

Date/Time Type Description Signal Details
2023-05-18 16:00 ESTNewsCabaletta Bio up 1%, prices $87M offeringN/A
2023-05-18 02:29 ESTNewsCabaletta Bio commences underwritten public offering of sharesN/A
2023-05-16 23:33 ESTNewsCabaletta Bio jumps 16% as FDA clears trial for myositis candidateN/A
2023-05-11 15:27 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.02N/A
2023-05-01 18:20 ESTNewsCabaletta's potential lupus drug CABA-201 gets FDA fast track tagN/A
2023-04-28 03:16 ESTNewsCabaletta Bio: Speculative Biotech With OpportunityN/A
2023-03-31 16:02 ESTNewsCabaletta CAR T cell therapy for lupus gets FDA nod to enter trialN/A
2023-03-31 16:02 ESTNews4 stocks to watch on Friday: Amazon, Kraft Heinz, and moreN/A
2023-03-16 13:19 ESTNewsCabaletta Bio GAAP EPS of -$0.52 misses by $0.08N/A
2023-01-27 17:59 ESTNewsCabaletta rises as Morgan Stanley upgrades citing new CAR-T assetN/A
2023-01-25 12:46 ESTNewsCabaletta: Adding To Position For 36% Return Potential After CABA-201 Rally (Technical Analysis)N/A
2022-12-08 20:30 ESTNewsCabaletta Bio dips on announcing $35M offeringN/A
2022-11-10 11:40 ESTNewsCabaletta Bio GAAP EPS of -$0.39 beats by $0.09N/A
2022-08-30 16:03 ESTNewsCabaletta downgraded at Morgan Stanley on upcoming data for lead assetN/A
2022-08-11 21:46 ESTNewsCabaletta Bio GAAP EPS of -$0.45 beats by $0.05N/A
2022-05-18 20:14 ESTNewsCabaletta Bio updates Phase 1 interim data for lead assetN/A
2022-05-12 11:04 ESTNewsCabaletta Bio GAAP EPS of -$0.45N/A
2022-03-18 09:46 ESTNewsCabaletta Bio GAAP EPS of -$0.49 beats by $0.11N/A
2021-12-14 08:41 ESTNewsCabaletta Bio tanks 34% on cell therapy data in early-stage study for pemphigus vulgarisN/A
2021-11-01 14:01 ESTNewsCabaletta Bio EPS beats by $0.05N/A
2021-11-01 14:01 ESTNewsCabaletta rises as skin diseases drug shown to be safe in early data of phase 1 trialN/A
2021-08-19 00:00 ESTNewsCabaletta Bio reports results from DesCAARTes trial in patients with pemphigus vulgarisN/A
2021-08-05 20:25 ESTNewsCabaletta Bio EPS beats by $0.03N/A
2021-03-18 15:25 ESTAnalyst RatingThe Analyst Target Price has increased from $20.33 to $22.25.Buy
2021-03-18 07:46 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 17:01 ESTNewsCabaletta Bio EPS misses by $0.04N/A
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$0.46 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-17 15:39 ESTEarnings EstimateAn EPS average of -$2.18 is estimated for the 2022 year.Sell
2021-01-20 12:58 ESTNewsCabaletta: DSG3-CAART's 1H 2021 Data Release Can Substantiate This Young BiotechN/A
2021-01-11 10:22 ESTAnalyst RatingThe Analyst Target Price has increased from $20 to $20.33.Buy
2021-01-09 03:37 ESTNewsChardan Capital initiates Cabaletta Bio with Buy ratingN/A
2020-12-10 06:47 ESTNewsDosing underway in Cabaletta Bio's DSG3-CAART study in a rare skin blistering disorderN/A
2020-12-04 06:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 15:51 ESTAnalyst RatingThe Analyst Target Price has decreased from $21.67 to $20.Neutral
2020-11-17 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 23:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 07:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 09:52 ESTNewsCabaletta Bio EPS beats by $0.08N/A
2020-11-11 09:52 ESTNewsCabaletta Bio +5% on Q3 results, pipeline updateN/A
2020-11-11 06:54 ESTEarnings EstimateAn EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021.Sell
2020-10-15 08:02 ESTNewsCabaletta Bio (CABA) Investor Presentation - SlideshowN/A
2020-10-14 11:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $22.5 to $21.67.Neutral
2020-10-08 21:07 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:25 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:18 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 03:29 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 23:40 ESTFinancialsCompany financials have been released.Neutral

About Cabaletta Bio, Inc (CABA):

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also include MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was founded in 2017 and is headquartered in Philadelphia, Pennsylvania.

CABA Quotes by TradingView

See Advanced Chart

General

  • Name Cabaletta Bio, Inc
  • Symbol CABA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 31
  • Fiscal Year EndDecember
  • IPO Date2019-10-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.cabalettabio.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.13
  • Next Year EPS Estimate -$2.45
  • Next Quarter EPS Estimate -$0.42
  • Return on Assets -17%
  • Return on Equity -27%
  • Earnings Per Share -$0.94
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 276.24 million
  • Analyst Target Price $22.25
View More

Share Statistics

  • Shares Outstanding 24.06 million
  • Shares Float 7.91 million
  • % Held by Insiders 523%
  • % Held by Institutions 67.4%
  • Shares Short 1.63 million
  • Shares Short Prior Month 1.61 million
  • Short Ratio 15.52
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • 52 Week High $16.38
  • 52 Week Low $6.07
  • 50 Day Moving Average 11.96
  • 200 Day Moving Average 12.4
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cabaletta Bio, Inc (CABA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cabaletta Bio, Inc (CABA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.40-$0.36-11.11%
2020-09-302020-11-10$N/A-$0.36-$0.4418.18%
2020-06-302020-08-06$N/A-$0.35-$0.3910.26%
2020-03-312020-05-12$N/A-$0.33-$0.23-43.48%
2019-12-312020-03-30$N/A-$0.33-$0.4729.79%
2019-09-302019-12-05$N/A-$1.21-$2.2646.46%

Cabaletta Bio, Inc (CABA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cabaletta Bio, Inc (CABA) Chart:

CABA chart by TradingView

Cabaletta Bio, Inc (CABA) News:

Below you will find a list of latest news for Cabaletta Bio, Inc (CABA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cabaletta Bio, Inc (CABA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-04-170.50CALL0 00TRUE00
2026-04-1710CALL0 0787.27TRUE00
2026-04-171.50CALL0 00TRUE00
2026-04-1720.8CALL0 50TRUE00
2026-04-172.50.7CALL25 4630TRUE0.70
2026-04-1730.2CALL1 6140TRUE0.20
2026-04-173.50.03CALL3 29891.1FALSE-0.03-0.5
2026-04-1740.01CALL0 3058222.43FALSE00
2026-04-174.50.6CALL0 34414.08FALSE00
2026-04-1750.06CALL0 200310.11FALSE00
2026-04-175.50CALL0 0781.97FALSE00
2026-04-177.50CALL0 0956.36FALSE00
2026-04-170.50PUT0 01065FALSE00
2026-04-1710PUT0 0674.34FALSE00
2026-04-171.50PUT0 01335.63FALSE00
2026-04-1720PUT0 0964.51FALSE00
2026-04-172.50.05PUT0 306224.67FALSE00
2026-04-1730.3PUT0 25162.83FALSE00
2026-04-173.51.02PUT0 1236.15TRUE00
2026-04-1740PUT0 080.12TRUE00
2026-04-174.50PUT0 0117.44TRUE00
2026-04-1750PUT0 00TRUE00
2026-04-175.50PUT0 00TRUE00
2026-04-177.50PUT0 00TRUE00
2026-05-150.50CALL0 00TRUE00
2026-05-1512.14CALL0 83335.63TRUE00
2026-05-151.51.7CALL0 255186.41TRUE00
2026-05-1521.2CALL1 1430184.25TRUE0.060.05
2026-05-152.50.75CALL91 1498675.72TRUE0.040.06
2026-05-1530.42CALL1 49783.32TRUE0.420
2026-05-153.50.25CALL2 94595.79FALSE0.10.67
2026-05-1540.15CALL19 532103.26FALSE0.040.36
2026-05-154.50.4CALL0 31129.69FALSE00
2026-05-1550.1CALL0 3387132.44FALSE00
2026-05-155.50CALL0 0203.66FALSE00
2026-05-157.50.04CALL0 1055188.91FALSE00
2026-05-150.50PUT0 0377.08FALSE00
2026-05-1510PUT0 0695.72FALSE00
2026-05-151.50PUT0 0473.41FALSE00
2026-05-1520.5PUT0 1342.09FALSE00
2026-05-152.50.15PUT0 457113.53FALSE00
2026-05-1530.2PUT0 10165.36FALSE00
2026-05-153.50.87PUT0 10098.49TRUE00
2026-05-1541.22PUT0 4106.57TRUE00
2026-05-154.51.5PUT0 295.51TRUE00
2026-05-1552.1PUT0 20115.01TRUE00
2026-05-155.50PUT0 00TRUE00
2026-05-157.54.37PUT33 33194.71TRUE4.370
2026-06-180.50CALL0 00TRUE00
2026-06-1810CALL0 0188.52TRUE00
2026-06-181.50CALL0 0126.49TRUE00
2026-06-1820CALL0 0107.4TRUE00
2026-06-182.50CALL0 095.49TRUE00
2026-06-1830.68CALL0 192.61TRUE00
2026-06-183.50.4CALL11 193.71FALSE0.010.03
2026-06-1840CALL0 0138.95FALSE00
2026-06-184.50CALL0 0159.81FALSE00
2026-06-1850CALL0 0176.98FALSE00
2026-06-185.50CALL0 0191.58FALSE00
2026-06-180.50PUT0 00FALSE00
2026-06-1810PUT0 0485.74FALSE00
2026-06-181.50PUT0 0330.64FALSE00
2026-06-1820PUT0 0239.12FALSE00
2026-06-182.50PUT0 0172.1FALSE00
2026-06-1830PUT0 0116.09FALSE00
2026-06-183.50PUT0 097.52TRUE00
2026-06-1840PUT0 086.25TRUE00
2026-06-184.50PUT0 0116.44TRUE00
2026-06-1850PUT0 0122.4TRUE00
2026-06-185.50PUT0 0124.49TRUE00
2026-07-170.50CALL0 00TRUE00
2026-07-1710CALL0 0154.9TRUE00
2026-07-171.50CALL0 0102.87TRUE00
2026-07-1721.4CALL0 30170.67TRUE00
2026-07-172.50CALL0 0109.73TRUE00
2026-07-1730.78CALL0 1109.67TRUE00
2026-07-173.50.65CALL0 1116.13FALSE00
2026-07-1740CALL0 0123.04FALSE00
2026-07-174.50CALL0 0132.79FALSE00
2026-07-1750CALL0 0147.13FALSE00
2026-07-175.50CALL0 0159.31FALSE00
2026-07-170.50PUT0 00FALSE00
2026-07-1710PUT0 0405.81FALSE00
2026-07-171.50PUT0 0276.32FALSE00
2026-07-1720PUT0 0199.96FALSE00
2026-07-172.50PUT0 0144.09FALSE00
2026-07-1730PUT0 0105.75FALSE00
2026-07-173.50PUT0 0112.99TRUE00
2026-07-1740PUT0 0120.41TRUE00
2026-07-174.50PUT0 0106.69TRUE00
2026-07-1750PUT0 0112.52TRUE00
2026-07-175.50PUT0 0115.45TRUE00
2026-08-210.52.6CALL0 20TRUE00
2026-08-2110CALL0 00TRUE00
2026-08-211.51.65CALL0 13109.55TRUE00
2026-08-2121.11CALL0 57134.29TRUE00
2026-08-212.51.21CALL5 13934120.33TRUE1.210
2026-08-2130.85CALL0 3687114.74TRUE00
2026-08-213.50.45CALL0 113139.36FALSE00
2026-08-2141.1CALL0 26111.27FALSE00
2026-08-214.50CALL0 0126.29FALSE00
2026-08-2150.5CALL0 91132.04FALSE00
2026-08-215.50.5CALL0 9135.81FALSE00
2026-08-217.50.25CALL6 925128.96FALSE0.250
2026-08-210.50PUT0 00FALSE00
2026-08-2110PUT0 0347.86FALSE00
2026-08-211.50PUT0 0236.94FALSE00
2026-08-2120PUT0 0171.61FALSE00
2026-08-212.50.95PUT0 21136.59FALSE00
2026-08-2130.8PUT0 0105.45FALSE00
2026-08-213.50PUT0 0110.83TRUE00
2026-08-2140PUT0 0110.57TRUE00
2026-08-214.50PUT0 0106.17TRUE00
2026-08-2152.35PUT0 19104.95TRUE00
2026-08-215.50PUT0 0115.62TRUE00
2026-08-217.50PUT0 0112.45TRUE00
2026-09-180.52.7CALL0 8239.16TRUE00
2026-09-1812.6CALL0 7169.73TRUE00
2026-09-181.51.25CALL0 75144.35TRUE00
2026-09-1821.65CALL0 767150.4TRUE00
2026-09-182.51.1CALL4 6278126.44TRUE1.10
2026-09-1831.25CALL1 3528144.26TRUE1.250
2026-09-183.50.85CALL11 383113.58FALSE0.850
2026-09-1840.54CALL0 107124.51FALSE00
2026-09-184.50.5CALL0 42102.27FALSE00
2026-09-1850.43CALL0 369104.23FALSE00
2026-09-185.50.45CALL0 36122.92FALSE00
2026-09-187.50.4CALL0 1005137.93FALSE00
2026-09-180.50PUT0 00FALSE00
2026-09-1810PUT0 0316.23FALSE00
2026-09-181.50.2PUT0 1215.46FALSE00
2026-09-1820PUT0 0156.14FALSE00
2026-09-182.50.77PUT0 40128.27FALSE00
2026-09-1831.25PUT0 38116.03FALSE00
2026-09-183.51.65PUT0 7119.64TRUE00
2026-09-1841.87PUT0 35113.01TRUE00
2026-09-184.52.2PUT0 1121.27TRUE00
2026-09-1852.7PUT0 8108.86TRUE00
2026-09-185.50PUT0 0106.04TRUE00
2026-09-187.50PUT0 0120.98TRUE00
2026-11-200.50CALL0 0200.7TRUE00
2026-11-2011.94CALL0 2193.48TRUE00
2026-11-201.50CALL0 0176.36TRUE00
2026-11-2021.5CALL0 10150.94TRUE00
2026-11-202.50CALL0 0149.98TRUE00
2026-11-2031.18CALL0 11145.33TRUE00
2026-11-203.51.2CALL15 0133.02FALSE1.20
2026-11-2040CALL0 0130.52FALSE00
2026-11-204.50CALL0 0131.42FALSE00
2026-11-2050.8CALL0 20123.17FALSE00
2026-11-205.50CALL0 0118.73FALSE00
2026-11-200.50PUT0 00FALSE00
2026-11-2010PUT0 0268.73FALSE00
2026-11-201.50PUT0 0183.21FALSE00
2026-11-2020.55PUT0 1149.46FALSE00
2026-11-202.51PUT0 6157.04FALSE00
2026-11-2031PUT0 10140.3FALSE00
2026-11-203.50PUT0 0134.98TRUE00
2026-11-2040PUT0 0133.2TRUE00
2026-11-204.50PUT0 0124.51TRUE00
2026-11-2050PUT0 0124.59TRUE00
2026-11-205.50PUT0 0123.27TRUE00
2027-01-150.52.56CALL0 1178.07TRUE00
2027-01-1512.1CALL0 12106.74TRUE00
2027-01-151.52.4CALL0 1127.09TRUE00
2027-01-1521.6CALL0 6689.37TRUE00
2027-01-152.51.5CALL0 368139.65TRUE00
2027-01-1531.55CALL0 433146.2TRUE00
2027-01-153.51.22CALL0 41103.54FALSE00
2027-01-1541CALL0 159150.37FALSE00
2027-01-154.51.05CALL0 16159.92FALSE00
2027-01-1550.8CALL0 1081134.57FALSE00
2027-01-155.50.75CALL0 27151.03FALSE00
2027-01-150.50PUT0 00FALSE00
2027-01-1510PUT0 0241.08FALSE00
2027-01-151.50.65PUT0 12164.45FALSE00
2027-01-1520.75PUT0 56141.78FALSE00
2027-01-152.50.85PUT0 16128.68FALSE00
2027-01-1531.3PUT0 1131.83FALSE00
2027-01-153.50PUT0 0147.49TRUE00
2027-01-1542PUT0 50144.56TRUE00
2027-01-154.52.7PUT0 2140.5TRUE00
2027-01-1552.6PUT0 5149.6TRUE00
2027-01-155.53PUT0 50148.16TRUE00
2028-01-210.52.8CALL0 270TRUE00
2028-01-2112.6CALL2 2128.81TRUE2.60
2028-01-211.51.86CALL0 44174.71TRUE00
2028-01-2122.85CALL1 315219.01TRUE2.850
2028-01-212.52CALL0 240163.66TRUE00
2028-01-2132.3CALL1 135155.42TRUE-0.1-0.04
2028-01-213.52CALL0 10168.2FALSE00
2028-01-2141.75CALL0 45163.93FALSE00
2028-01-214.51.95CALL0 10164.37FALSE00
2028-01-2151.5CALL0 104155.64FALSE00
2028-01-215.51.52CALL0 110159.77FALSE00
2028-01-210.50PUT0 00FALSE00
2028-01-2110PUT0 0214.76FALSE00
2028-01-211.50PUT0 0180.12FALSE00
2028-01-2121.1PUT0 5173.49FALSE00
2028-01-212.51.5PUT0 40173.44FALSE00
2028-01-2132PUT0 705172.15FALSE00
2028-01-213.52.3PUT0 4154.93TRUE00
2028-01-2140PUT0 0167.83TRUE00
2028-01-214.50PUT0 0165.24TRUE00
2028-01-2153.5PUT0 45146.11TRUE00
2028-01-215.53.9PUT0 2159.64TRUE00

Latest CABA Trades:

Date Shares Price
Jun 13, 2022 7:37 PM EST1$1.08
Jun 13, 2022 7:37 PM EST6$1.08
Jun 13, 2022 7:51 PM EST7$1.06
Jun 13, 2022 7:57 PM EST7$1.06
Jun 13, 2022 7:58 PM EST7$1.055

Cabaletta Bio, Inc (CABA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025941/0000899243-19-025941-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025942/0000899243-19-025942-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025943/0000899243-19-025943-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025946/0000899243-19-025946-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319025947/0000899243-19-025947-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026016/0000899243-19-026016-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026017/0000899243-19-026017-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026018/0000899243-19-026018-index.htm
2019-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026020/0000899243-19-026020-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026345/0000899243-19-026345-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924319026346/0000899243-19-026346-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004509/0000899243-20-004509-index.htm
2020-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320004511/0000899243-20-004511-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006864/0000899243-20-006864-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006865/0000899243-20-006865-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320006867/0000899243-20-006867-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000089924320025326/0000899243-20-025326-index.htm
2020-07-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000090266420002724/0000902664-20-002724-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963819000988/0000929638-19-000988-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000092963820000331/0000929638-20-000331-index.htm
2019-10-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919056233/0001104659-19-056233-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919057348/0001104659-19-057348-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-11-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1759138/000110465919061822/0001104659-19-061822-index.htm
2019-10-24S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519273939/0001193125-19-273939-index.htm
2019-10-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1759138/000119312519274807/0001193125-19-274807-index.htm
2019-10-29S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519277804/0001193125-19-277804-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312519278927/0001193125-19-278927-index.htm
2019-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312519287367/0001193125-19-287367-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520005110/0001193125-20-005110-index.htm
2020-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520017724/0001193125-20-017724-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520038349/0001193125-20-038349-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520042689/0001193125-20-042689-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520090013/0001193125-20-090013-index.htm
2020-03-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520091086/0001193125-20-091086-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1759138/000119312520115863/0001193125-20-115863-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520134391/0001193125-20-134391-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520139782/0001193125-20-139782-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520153792/0001193125-20-153792-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1759138/000119312520211336/0001193125-20-211336-index.htm
2019-10-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001374/0001193805-19-001374-index.htm
2019-10-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1759138/000119380520000185/0001193805-20-000185-index.htm
2019-12-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459019045375/0001564590-19-045375-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/0001564590-20-013929-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020024508/0001564590-20-024508-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1759138/000156459020037278/0001564590-20-037278-index.htm
2019-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1759138/999999999519002384/9999999995-19-002384-index.htm

Cabaletta Bio, Inc (CABA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cabaletta Bio, Inc (CABA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 523%
Institutional Ownership: 6740%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-295AM Ventures V, L.P.10% Share HolderBuy454,545.0011.004,999,995.00454,545.00https://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm
2019-10-29James E Flynn10% Share HolderBuy700,000.0011.007,700,000.00700,000.00https://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm